Back to results
US 2021/0228566 A1Published application
Methods of treating a neurological or psychiatric disorder
OwnerGuriqbal S. Nandra, Irvin M. Weismaninventors
Life of this patent
Estimating the term…
Abstract
Provided are methods of administering a vesicular monoamine transport 2 (VMAT2) inhibitor chosen from valbenazine, or a pharmaceutically acceptable salt and/or isotopic variant thereof, to a patient in need thereof.
Claims2
A method of administering a vesicular monoamine transport 2 (VMAT2) inhibitor chosen from valbenazine, or a pharmaceutically acceptable salt and/or isotopic variant thereof, to a patient in need thereof, comprising:
- administering a therapeutically effective amount of the VAMT2 inhibitor to the patient;
- and
- monitoring the patient for one or more exposure-related adverse reactions,
- wherein the one or more exposure-related adverse reactions is chosen from hypersensitivity and/or dermatological reactions.
1 more element
-117. (canceled)
Dependencies are inferred from the claim text.